In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

5 Things to Know is CNBC's Morning Squawk newsletter, a before-the-bell briefing on the most important news, trends and analysis that investors need to start their trading day. Subscribe here to ...

Below is an excerpt from the Preview newsletter, which goes out every Thursday morning to help you plan your weekend and beyond. Don't miss out! Sign up here to get it right in your inbox every week.

If the Bears or any other professional team wants a new stadium, they should use ...